Corticosteroid-Induced Adverse Psychiatric Effects: Incidence, Diagnosis and Management

ISSN： 0114-5916

Source： Drug Safety, Vol.22, Iss.2, 2000-02, pp. : 111-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroid-Induced Osteoporosis: Detection and Management

By Adachi J.D. Papaioannou A.

Drug Safety, Vol. 24, Iss. 8, 2001-01 ,pp. : 607-624

Adis International

Access to resources Recommend Favorite

Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention

By Fardet Laurence Kassar Abdulrhaman

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 861-881

Adis International

Access to resources Recommend Favorite

Adverse Effects of Contrast Media: Incidence, Prevention and Management

By Thomsen H.S.

Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Adverse Gastrointestinal Effects of Mycophenolate Mofetil: Aetiology, Incidence and Management

By Behrend M.

Drug Safety, Vol. 24, Iss. 9, 2001-01 ,pp. : 645-663

Adis International

Access to resources Recommend Favorite

Recommendations for preventing, treating corticosteroid-induced bone loss

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite